FMT trial in refractory intestinal diseases

Preliminary study for examining the safety and efficacy of fecal transplantation therapy in refractory intestinal diseases - Preliminary study for FMT in refractory intestinal diseases

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs041180115

Enrollment

Registered

2019-03-19

Start date

2015-10-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory intestinal diseases

Interventions

FMT should be performed by upper route or by colonoscopy. Recipients should be monitored for the occurrence of possible of acute complications and clinical data.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Male and female patients over 20 years old with intractable bowel disease Crohn's disease, intestinal Behcet, ulcerative colitis, irritable bowel syndrome, collagenous enteropathy

Exclusion criteria

Exclusion criteria: 1. Patient is under 20 years old 2. Patient do not agree with this research 3. Patient is pregnant 4. When the research leader judges that there is no disease activity or judges it as inappropriate

Design outcomes

Primary

Measure	Time frame
Improvement of symptoms of recipients after fecal microbiota transplantation	—

Secondary

Measure	Time frame
Changes before and after treatment of gut microbiota	—

Contacts

Public ContactTsunaki Sawada

Nagoya University Hospital

t.sawada@med.nagoya-u.ac.jp+81-52-744-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026